心血管疾病：遗传风险评分的崛起。
Cardiovascular disease: The rise of the genetic risk score.
机构信息
Center for Inherited Cardiovascular Disease, Stanford University, Stanford, California, United States of America.
出版信息
PLoS Med. 2018 Mar 30;15(3):e1002546. doi: 10.1371/journal.pmed.1002546. eCollection 2018 Mar.
Abstract
In a Perspective, Joshua Knowles and Euan Ashley discuss the potential for use of genetic risk scores in clinical practice.
摘要
在一篇观点文章中，Joshua Knowles 和 Euan Ashley 探讨了遗传风险评分在临床实践中的应用潜力。
相似文献
1
Cardiovascular disease: The rise of the genetic risk score.心血管疾病：遗传风险评分的崛起。
PLoS Med. 2018 Mar 30;15(3):e1002546. doi: 10.1371/journal.pmed.1002546. eCollection 2018 Mar.
2
From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment.从全基因组关联研究到孟德尔随机化：理解心血管疾病因果关系、发病机制、预防和治疗的新机遇。
Cardiovasc Res. 2018 Jul 15;114(9):1192-1208. doi: 10.1093/cvr/cvy045.
3
Clinical validation of genetic markers for improved risk estimation.遗传标志物的临床验证可提高风险评估的准确性。
Eur J Prev Cardiol. 2012 Aug;19(2 Suppl):25-32. doi: 10.1177/2047487312448993.
4
Clinical and genetic association of serum ceruloplasmin with cardiovascular risk.血清铜蓝蛋白与心血管风险的临床和遗传关联。
Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):516-22. doi: 10.1161/ATVBAHA.111.237040. Epub 2011 Nov 10.
5
[Genetic variants, cardiovascular risk and genome-wide association studies].[基因变异、心血管风险与全基因组关联研究]
Rev Esp Cardiol. 2011 Jun;64(6):509-14. doi: 10.1016/j.recesp.2011.01.010. Epub 2011 May 6.
6
Building genetic scores to predict risk of complex diseases in humans: is it possible?构建基因评分以预测人类复杂疾病风险：这可行吗？
Diabetes. 2010 Nov;59(11):2729-31. doi: 10.2337/db10-1081.
7
Genetic association studies in cardiovascular diseases: Do we have enough power?心血管疾病的基因关联研究：我们有足够的效力吗？
Trends Cardiovasc Med. 2017 Aug;27(6):397-404. doi: 10.1016/j.tcm.2017.03.005. Epub 2017 Mar 24.
8
Sex matters to the heart: A special issue dedicated to the impact of sex related differences of cardiovascular diseases.性别对心脏至关重要：一个致力于探讨心血管疾病性别差异影响的特刊。
Atherosclerosis. 2015 Jul;241(1):205-7. doi: 10.1016/j.atherosclerosis.2015.05.003. Epub 2015 May 15.
9
Genetic Architecture of the Cardiovascular Risk Proteome.心血管风险蛋白质组的遗传结构。
Circulation. 2018 Mar 13;137(11):1158-1172. doi: 10.1161/CIRCULATIONAHA.117.029536. Epub 2017 Dec 19.
10
DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.在全国范围内设计（DIAMOND-FH）中诊断和管理家族性高胆固醇血症：瑞士的流行情况、临床特征和临床评分的诊断价值。
Atherosclerosis. 2018 Oct;277:282-288. doi: 10.1016/j.atherosclerosis.2018.08.009.
引用本文的文献
1
Cellular and Molecular Bases for the Application of Polyphenols in the Prevention and Treatment of Cardiovascular Disease.多酚类物质在心血管疾病防治中应用的细胞与分子基础
Diseases. 2025 Jul 15;13(7):221. doi: 10.3390/diseases13070221.
2
The relationship of genetic signature for cardiometabolic risk with biomarkers of inflammatory and oxidative stress in diabetic patients.糖尿病患者中心血管代谢风险的基因特征与炎症和氧化应激生物标志物的关系。
BMC Endocr Disord. 2025 Jul 1;25(1):148. doi: 10.1186/s12902-025-01973-6.
3
Evaluation of Machine Learning and Traditional Statistical Models to Assess the Value of Stroke Genetic Liability for Prediction of Risk of Stroke Within the UK Biobank.评估机器学习和传统统计模型以评估中风遗传易感性在英国生物银行中对中风风险预测的价值。
Healthcare (Basel). 2025 Apr 26;13(9):1003. doi: 10.3390/healthcare13091003.
4
Genetic Regulation of Alternative Polyadenylation Provides Novel Insights into Molecular Mechanisms Underlying Non-small Cell Lung Cancer.可变聚腺苷酸化的遗传调控为非小细胞肺癌潜在分子机制提供了新见解。
Adv Sci (Weinh). 2025 Jul;12(26):e2502008. doi: 10.1002/advs.202502008. Epub 2025 Apr 26.
5
Treating Cardiovascular Disorders with Personalized Medicine.用个性化医疗治疗心血管疾病。
Cardiovasc Hematol Disord Drug Targets. 2025;25(2):98-118. doi: 10.2174/011871529X361429250215190129.
6
Genome-wide association study on chronic postsurgical pain in the UK Biobank.英国生物银行中慢性术后疼痛的全基因组关联研究。
Br J Anaesth. 2025 Mar;134(3):783-792. doi: 10.1016/j.bja.2024.12.008. Epub 2025 Jan 25.
7
Polygenic Risk Score Implementation into Clinical Practice for Primary Prevention of Cardiometabolic Disease.多基因风险评分在心血管代谢疾病一级预防临床实践中的应用
Genes (Basel). 2024 Dec 9;15(12):1581. doi: 10.3390/genes15121581.
8
Genetic risk score for coronary artery calcification and its predictive ability for coronary artery disease.冠状动脉钙化的遗传风险评分及其对冠状动脉疾病的预测能力。
Am J Prev Cardiol. 2024 Oct 10;20:100884. doi: 10.1016/j.ajpc.2024.100884. eCollection 2024 Dec.
9
Diabetic Heart Disease: An Intricate Interplay of a Widespread Metabolic Disorder with the Cardiovascular System.糖尿病性心脏病：一种广泛存在的代谢紊乱与心血管系统之间的复杂相互作用。
Curr Diabetes Rev. 2025;21(6):93-101. doi: 10.2174/0115733998305019240702095537.
10
Clinical use of polygenic risk scores for detection of peripheral artery disease and cardiovascular events.多基因风险评分在检测外周动脉疾病和心血管事件中的临床应用。
PLoS One. 2024 May 17;19(5):e0303610. doi: 10.1371/journal.pone.0303610. eCollection 2024.
本文引用的文献
1
Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention.对 480,000 名成年人的冠心病的基因组风险预测：对一级预防的影响。
J Am Coll Cardiol. 2018 Oct 16;72(16):1883-1893. doi: 10.1016/j.jacc.2018.07.079.
2
Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits.使用来自 32 种复杂性状的全基因组关联研究的汇总水平统计数据估计复杂效应大小分布。
Nat Genet. 2018 Sep;50(9):1318-1326. doi: 10.1038/s41588-018-0193-x. Epub 2018 Aug 13.
3
Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations With Midlife Blood Pressure Levels and Cardiovascular Events.遗传易感性与高血压和生活方式因素：与中年血压水平和心血管事件的关联。
Circulation. 2018 Feb 13;137(7):653-661. doi: 10.1161/CIRCULATIONAHA.117.030898. Epub 2017 Dec 18.
4
First things first: risk model performance metrics should reflect the clinical application.首先：风险模型性能指标应反映临床应用情况。
Stat Med. 2017 Dec 10;36(28):4503-4508. doi: 10.1002/sim.7341.
5
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017美国心脏病学会/美国心脏协会/美国医师协会/美国心脏病学学会/美国预防医学学院/美国老年病学会/美国药学协会/美国血液学会/美国预防医学学会/美国医学协会/美国初级保健医师学会成人高血压预防、检测、评估和管理指南：美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248. doi: 10.1016/j.jacc.2017.11.006. Epub 2017 Nov 13.
6
Impact of a Genetic Risk Score for Coronary Artery Disease on Reducing Cardiovascular Risk: A Pilot Randomized Controlled Study.冠心病遗传风险评分对降低心血管风险的影响：一项试点随机对照研究。
Front Cardiovasc Med. 2017 Aug 14;4:53. doi: 10.3389/fcvm.2017.00053. eCollection 2017.
7
Informed Consent.知情同意书
N Engl J Med. 2017 Mar 2;376(9):856-867. doi: 10.1056/NEJMra1603773.
8
Genetics: Implications for Prevention and Management of Coronary Artery Disease.遗传学：对冠状动脉疾病的预防和管理的启示。
J Am Coll Cardiol. 2016 Dec 27;68(25):2797-2818. doi: 10.1016/j.jacc.2016.10.039.
9
Feasibility of Obtaining Measures of Lifestyle From a Smartphone App: The MyHeart Counts Cardiovascular Health Study.从智能手机应用程序获取生活方式措施的可行性：MyHeart Counts 心血管健康研究。
JAMA Cardiol. 2017 Jan 1;2(1):67-76. doi: 10.1001/jamacardio.2016.4395.
10
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease.遗传风险、对健康生活方式的坚持与冠心病
N Engl J Med. 2016 Dec 15;375(24):2349-2358. doi: 10.1056/NEJMoa1605086. Epub 2016 Nov 13.
Zotero 插件